SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
mds22401supptable1.doc52KSupporting Information Table 1. Baseline medications for each subject.
mds22401supptable2.doc36KSupporting Information Table 2. Means (SD) for UPDRS scores, walking time and tapping for placebo and glutathione groups. P-values represent changes in glutathione vs. changes in placebo from baseline to week 4 (treatment period) and from week 4 to week 12 (no treatment follow-up period).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.